{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:46:54Z","timestamp":1792014414628,"version":"4.4.0"},"reference-count":85,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T00:00:00Z","timestamp":1691280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of Excellence 2023\/2027, MUR, Italy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>The mucosal barrier constitutes a huge surface area, close to 40 m2 in humans, located mostly in the respiratory, gastrointestinal and urogenital tracts and ocular cavities. It plays a crucial role in tissue interactions with the microbiome, dietary antigens and other environmental materials. Effective vaccinations to achieve highly protective mucosal immunity are evolving strategies to counteract several serious diseases including tuberculosis, diphtheria, influenzae B, severe acute respiratory syndrome, Human Papilloma Virus infection and Acquired Immune Deficiency Syndrome. Interestingly, one of the reasons behind the rapid spread of severe acute respiratory syndrome coronavirus 2 variants has been the weakness of local immunization at the level of the respiratory mucosa. Mucosal vaccines can outperform parenteral vaccination as they specifically elicit protective mucosal immune responses blocking infection and transmission. In this scenario, chitosan-based nanovaccines are promising adjuvants-carrier systems that rely on the ability of chitosan to cross tight junctions and enhance particle uptake due to chitosan-specific mucoadhesive properties. Indeed, chitosan not only improves the adhesion of antigens to the mucosa promoting their absorption but also shows intrinsic immunostimulant abilities. Furthermore, by finely tuning the colloidal properties of chitosan, it can provide sustained antigen release to strongly activate the humoral defense. In the present review, we agnostically discuss the potential reasons why chitosan-based vaccine carriers, that efficiently elicit strong immune responses in experimental setups and in some pre-clinical\/clinical studies, are still poorly considered for therapeutic formulations.<\/jats:p>","DOI":"10.3390\/vaccines11081333","type":"journal-article","created":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T10:01:53Z","timestamp":1691316113000},"page":"1333","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Efficiency of Chitosan Nanocarriers in Vaccinology for Mucosal Immunization"],"prefix":"10.3390","volume":"11","author":[{"given":"Salvatore Calogero","family":"Gaglio","sequence":"first","affiliation":[{"name":"Department of Biotechnology, University of Verona, C\u00e0 Vignal 1, Strada Le Grazie 15, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8291-0523","authenticated-orcid":false,"given":"Massimiliano","family":"Perduca","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, University of Verona, C\u00e0 Vignal 1, Strada Le Grazie 15, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2168-4144","authenticated-orcid":false,"given":"Donato","family":"Zipeto","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Strada Le Grazie 8, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9662-3007","authenticated-orcid":false,"given":"Giuseppe","family":"Bardi","sequence":"additional","affiliation":[{"name":"Nanobiointeractions & Nanodiagnostics, Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMra1204186","article-title":"Designing Tomorrow\u2019s Vaccines","volume":"368","author":"Nabel","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Lin, C.-H., Lin, C.-J., Kuo, Y.-W., Wang, J.-Y., Hsu, C.-L., Chen, J.-M., Cheng, W.-C., and Lee, L.-N. (2014). Tuberculosis mortality: Patient characteristics and causes. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-5"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0140-6736(10)60549-1","article-title":"Global, regional, and national causes of child mortality in 2008: A systematic analysis","volume":"375","author":"Black","year":"2010","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5501\/wjv.v11.i5.221","article-title":"Mucosal COVID-19 vaccines: Risks, benefits and control of the pandemic","volume":"11","author":"Miteva","year":"2022","journal-title":"World J. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines\u2014Fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: From basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"611337","DOI":"10.3389\/fimmu.2020.611337","article-title":"Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection","volume":"11","author":"Russell","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1128\/IAI.00786-13","article-title":"Mucosal Vaccination against Tuberculosis Using Inert Bioparticles","volume":"81","author":"Reljic","year":"2013","journal-title":"Infect. Immun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41467-019-08739-4","article-title":"HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge","volume":"10","author":"Jones","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijid.2019.03.022","article-title":"Mucosal and cutaneous Human Papillomavirus seroprevalence among adults in the prevaccine era in Germany\u2014Results from a nationwide population-based survey","volume":"83","author":"Loenenbach","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00253-021-11713-0","article-title":"Current view on novel vaccine technologies to combat human infectious diseases","volume":"106","year":"2022","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s13770-021-00373-w","article-title":"Mucosal Vaccine Delivery Using Mucoadhesive Polymer Particulate Systems","volume":"18","author":"Cho","year":"2021","journal-title":"Tissue Eng. Regen. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijbiomac.2021.12.129","article-title":"Recent advances on chitosan as an adjuvant for vaccine delivery","volume":"200","author":"Dmour","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijpharm.2015.06.021","article-title":"Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin\/chitosan nanoparticles","volume":"491","author":"Barbieri","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijpharm.2013.07.079","article-title":"Chitosan\/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: In vitro and in vivo evaluation","volume":"457","author":"Feng","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajps.2017.09.001","article-title":"Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brain","volume":"13","author":"Liu","year":"2018","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Cao, Y., Tan, Y.F., Wong, Y.S., Liew, M.W.J., and Venkatraman, S. (2019). Recent Advances in Chitosan-Based Carriers for Gene Delivery. Mar. Drugs, 17.","DOI":"10.3390\/md17060381"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"643953","DOI":"10.3389\/fcimb.2021.643953","article-title":"Chitosan-Based Nanoparticles Against Viral Infections","volume":"11","author":"Boroumand","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_19","unstructured":"Nataro, J.P., Cohen, P.S., Mobley, H.L.T., and Weiser, J.N. (2014). Colonization of Mucosal Surfaces, ASM Press."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/14760584.2022.2053678","article-title":"Thermostable vaccines: An innovative concept in vaccine development","volume":"21","author":"Kumar","year":"2022","journal-title":"Expert Rev. Vaccines"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4161\/hv.4.1.4747","article-title":"Evidence based route of administration of vaccines","volume":"4","author":"Cook","year":"2008","journal-title":"Hum. Vaccin."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jconrel.2010.08.012","article-title":"Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems","volume":"147","author":"Mohanan","year":"2010","journal-title":"J. Control. Release"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"645210","DOI":"10.3389\/fimmu.2021.645210","article-title":"Vaccine Inoculation Route Modulates Early Immunity and Consequently Antigen-Specific Immune Response","volume":"12","author":"Rosenbaum","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_24","unstructured":"Yu, C., and Walter, M. (2020). Needleless Injectors for the Administration of Vaccines: A Review of Clinical Effectiveness, CADTH Rapid Response Reports."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15761\/GVI.1000128","article-title":"Comparison of systemic and mucosal immunization with replicating Single cycle Adenoviruses","volume":"3","author":"Matchett","year":"2018","journal-title":"Glob. Vaccines Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"8303648","DOI":"10.1155\/2019\/8303648","article-title":"Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines","volume":"2019","author":"Criscuolo","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nri1728","article-title":"Immunization without needles","volume":"5","author":"Mitragotri","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41541-021-00320-9","article-title":"Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets","volume":"6","author":"Luczo","year":"2021","journal-title":"Npj Vaccines"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"eabd2223","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"eabf1555","DOI":"10.1126\/scitranslmed.abf1555","article-title":"Enhanced SARS-CoV-2 neutralization by dimeric IgA","volume":"13","author":"Wang","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s43856-021-00039-7","article-title":"Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus na\u00efve","volume":"1","author":"Valenti","year":"2021","journal-title":"Commun. Med."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Focosi, D., Maggi, F., and Casadevall, A. (2022). Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence. Viruses, 14.","DOI":"10.3390\/v14020187"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e15326","DOI":"10.15252\/emmm.202115326","article-title":"BNT162b2 vaccine induces antibody release in saliva: A possible role for mucosal viral protection?","volume":"14","author":"Darwich","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: Potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"887729","DOI":"10.3389\/fcimb.2022.887729","article-title":"Mucosal Vaccination: A Promising Alternative Against Flaviviruses","volume":"12","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fimmu.2013.00222","article-title":"Secretory IgA: Designed for Anti-Microbial Defense","volume":"4","author":"Brandtzaeg","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrmicro2384","article-title":"The role of secretory antibodies in infection immunity","volume":"8","author":"Strugnell","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/pathogens3020390","article-title":"Secretory IgA is Concentrated in the Outer Layer of Colonic Mucus along with Gut Bacteria","volume":"3","author":"Rogier","year":"2014","journal-title":"Pathogens"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"eabd8003","DOI":"10.1126\/sciimmunol.abd8003","article-title":"Exploiting albumin as a mucosal vaccine chaperone for robust generation of lung-resident memory T cells","volume":"6","author":"Rakhra","year":"2021","journal-title":"Sci. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.immuni.2014.12.007","article-title":"Tissue-Resident Memory T Cells","volume":"41","author":"Schenkel","year":"2014","journal-title":"Immunity"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41385-020-0315-5","article-title":"CD4+ T cells persist for years in the human small intestine and display a TH1 cytokine profile","volume":"14","author":"Landsverk","year":"2021","journal-title":"Mucosal Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"710375","DOI":"10.3389\/fimmu.2021.710375","article-title":"The Roles of Tissue-Resident Memory T Cells in Lung Diseases","volume":"12","author":"Yuan","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/mi.2013.99","article-title":"Harnessing local and systemic immunity for vaccines against tuberculosis","volume":"7","author":"Beverley","year":"2014","journal-title":"Mucosal Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Shim, S., and Yoo, H.S. (2020). The Application of Mucoadhesive Chitosan Nanoparticles in Nasal Drug Delivery. Mar. Drugs, 18.","DOI":"10.3390\/md18120605"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Gong, X., Gao, Y., Shu, J., Zhang, C., and Zhao, K. (2022). Chitosan-Based Nanomaterial as Immune Adjuvant and Delivery Carrier for Vaccines. Vaccines, 10.","DOI":"10.3390\/vaccines10111906"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0144-8617(93)90140-Y","article-title":"Solution properties of chitosans: Conformation and chain stiffness of chitosans with different degrees of N-acetylation","volume":"22","author":"Anthonsen","year":"1993","journal-title":"Carbohydr. Polym."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1016\/j.actbio.2012.08.043","article-title":"Endotoxins affect bioactivity of chitosan derivatives in cultures of bone marrow-derived human mesenchymal stem cells","volume":"9","author":"Lieder","year":"2013","journal-title":"Acta Biomater."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jddst.2018.10.022","article-title":"Chitosan-based nanoparticles: An overview of biomedical applications and its preparation","volume":"49","author":"Naskar","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1586\/14760584.2015.956729","article-title":"Chitosan-based vaccine adjuvants: Incomplete characterization complicates preclinical and clinical evaluation","volume":"14","author":"Vasiliev","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ijbiomac.2019.10.113","article-title":"Chitosan as an environment friendly biomaterial\u2014A review on recent modifications and applications","volume":"150","author":"Bakshi","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"104849","DOI":"10.1016\/j.reactfunctpolym.2021.104849","article-title":"Preparation methods and applications of chitosan nanoparticles; with an outlook toward reinforcement of biodegradable packaging","volume":"161","author":"Yanat","year":"2021","journal-title":"React. Funct. Polym."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(01)00171-5","article-title":"Chitosan as a novel nasal delivery system for vaccines","volume":"51","author":"Illum","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijbiomac.2020.03.065","article-title":"Chitosan, N,N,N-trimethyl chitosan (TMC) and 2-hydroxypropyltrimethyl ammonium chloride chitosan (HTCC): The potential immune adjuvants and nano carriers","volume":"154","author":"Zhao","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ajps.2022.04.002","article-title":"New modular platform based on multi-adjuvanted amphiphilic chitosan nanoparticles for efficient lipopeptide vaccine delivery against group A streptococcus","volume":"17","author":"Norpi","year":"2022","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_56","first-page":"165","article-title":"Chitosan based nanoparticles in mucosal vaccine delivery","volume":"73","author":"Mehrabi","year":"2018","journal-title":"Arch. Razi Inst."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1023\/A:1016418523014","article-title":"Nasal delivery of insulin using novel chitosan based formulations: A comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles","volume":"19","author":"Dyer","year":"2002","journal-title":"Pharm. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jconrel.2012.05.040","article-title":"Recent advances in nanocarrier-based mucosal delivery of biomolecules","volume":"161","author":"Kammona","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jcis.2022.06.126","article-title":"Mucus-penetrating nanoparticles based on chitosan grafted with various non-ionic polymers: Synthesis, structural characterisation and diffusion studies","volume":"626","author":"Ways","year":"2022","journal-title":"J. Colloid Interface Sci."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Torres, F.G., Troncoso, O.P., Pisani, A., Gatto, F., and Bardi, G. (2019). Natural Polysaccharide Nanomaterials: An Overview of Their Immunological Properties. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20205092"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12985-016-0598-z","article-title":"Responses of primary human nasal epithelial cells to EDIII-DENV stimulation: The first step to intranasal dengue vaccination","volume":"13","author":"Nantachit","year":"2016","journal-title":"Virol. J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1007\/s12274-021-4012-9","article-title":"A chitosan-mediated inhalable nanovaccine against SARS-CoV-2","volume":"15","author":"Zhuo","year":"2022","journal-title":"Nano Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7959","DOI":"10.2147\/IJN.S165876","article-title":"Novel application of trimethyl chitosan as an adjuvant in vaccine delivery","volume":"13","author":"Malik","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11095-014-1441-0","article-title":"Antigen-conjugated N-trimethylaminoethylmethacrylate Chitosan Nanoparticles Induce Strong Immune Responses After Nasal Administration","volume":"32","author":"Liu","year":"2015","journal-title":"Pharm. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1016\/j.vaccine.2010.06.121","article-title":"Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: Nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen","volume":"28","author":"Bal","year":"2010","journal-title":"Vaccine"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jconrel.2010.01.027","article-title":"Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine","volume":"144","author":"Hagenaars","year":"2010","journal-title":"J. Control. Release"},{"key":"ref_67","first-page":"197","article-title":"Development and Characterization of Tetanus Toxoid Loaded Trimethylchitosan Chloride Nanoparticles for Nasal Immunization","volume":"2","author":"Chadhar","year":"2012","journal-title":"Curr. Res. Pharm. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1016\/j.vaccine.2012.06.035","article-title":"Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics","volume":"30","author":"Tafaghodi","year":"2012","journal-title":"Vaccine"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"8769","DOI":"10.2147\/IJN.S149774","article-title":"Oral immunization of mice with Omp31-loaded N-trimethyl chitosan nanoparticles induces high protection against Brucella melitensis infection","volume":"12","author":"Abkar","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12951-021-00983-5","article-title":"Intranasal immunization with O-2\u2032-Hydroxypropyl trimethyl ammonium chloride chitosan nanoparticles loaded with Newcastle disease virus DNA vaccine enhances mucosal immune response in chickens","volume":"19","author":"Zhao","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1166\/jnn.2015.9252","article-title":"Mannosylated Chitosan Nanoparticles Based Macrophage-Targeting Gene Delivery System Enhanced Cellular Uptake and Improved Transfection Efficiency","volume":"15","author":"Peng","year":"2015","journal-title":"J. Nanosci. Nanotechnol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijpharm.2008.04.010","article-title":"Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery","volume":"359","author":"Park","year":"2008","journal-title":"Int. J. Pharm."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3389\/fcimb.2017.00445","article-title":"Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge","volume":"7","author":"Wu","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Bedford, J.G., Caminschi, I., and Wakim, L.M. (2020). Intranasal Delivery of a Chitosan-Hydrogel Vaccine Generates Nasal Tissue Resident Memory CD8+ T Cells That Are Protective against Influenza Virus Infection. Vaccines, 8.","DOI":"10.3390\/vaccines8040572"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1128\/IAI.69.12.7481-7486.2001","article-title":"Nasal and Vaginal Vaccinations Have Differential Effects on Antibody Responses in Vaginal and Cervical Secretions in Humans","volume":"69","author":"Johansson","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1128\/iai.65.7.2676-2684.1997","article-title":"Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina","volume":"65","author":"Bergquist","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1128\/IAI.71.2.726-732.2003","article-title":"Protective Levels of Diphtheria-Neutralizing Antibody Induced in Healthy Volunteers by Unilateral Priming-Boosting Intranasal Immunization Associated with Restricted Ipsilateral Mucosal Secretory Immunoglobulin A","volume":"71","author":"Mills","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.vaccine.2003.09.012","article-title":"Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: Enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan","volume":"22","author":"McNeela","year":"2004","journal-title":"Vaccine"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1128\/IAI.73.12.8256-8265.2005","article-title":"Induction of Protective Serum Meningococcal Bactericidal and Diphtheria-Neutralizing Antibodies and Mucosal Immunoglobulin A in Volunteers by Nasal Insufflations of the Neisseria meningitidis Serogroup C Polysaccharide-CRM197 Conjugate Vaccine Mixed with Chitosan","volume":"73","author":"Huo","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1086\/657087","article-title":"Adjuvanted Intranasal Norwalk Virus-Like Particle Vaccine Elicits Antibodies and Antibody-Secreting Cells That Express Homing Receptors for Mucosal and Peripheral Lymphoid Tissues","volume":"202","author":"Pasetti","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Shalaby, E.A. (2017). Biological Activities and Application of Marine Polysaccharides, InTech.","DOI":"10.5772\/62752"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/07388551.2021.2004989","article-title":"Shellfish industrial waste reuse","volume":"43","author":"Oliveira","year":"2023","journal-title":"Crit. Rev. Biotechnol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Bellich, B., D\u2019Agostino, I., Semeraro, S., Gamini, A., and Ces\u00e0ro, A. (2016). \u201cThe Good, the Bad and the Ugly\u201d of Chitosans. Mar. Drugs, 14.","DOI":"10.3390\/md14050099"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1208\/s12249-014-0177-9","article-title":"Nanomedicine Scale-up Technologies: Feasibilities and Challenges","volume":"15","author":"Paliwal","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0169-409X(01)00197-1","article-title":"Chitosan for mucosal vaccination","volume":"52","author":"Verhoef","year":"2001","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/8\/1333\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:26:45Z","timestamp":1760128005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/8\/1333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,6]]},"references-count":85,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["vaccines11081333"],"URL":"https:\/\/doi.org\/10.3390\/vaccines11081333","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,6]]}}}